Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy

J Pediatr. 1990 May;116(5):747-50. doi: 10.1016/s0022-3476(05)82665-4.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Blood Glucose / analysis
  • Female
  • Follow-Up Studies
  • Growth / drug effects*
  • Growth Hormone / pharmacokinetics
  • Humans
  • Hyperinsulinism / blood
  • Hyperinsulinism / drug therapy*
  • Hyperinsulinism / physiopathology
  • Hypoglycemia / blood
  • Hypoglycemia / drug therapy*
  • Hypoglycemia / physiopathology
  • Infant
  • Infant, Newborn
  • Insulin / pharmacokinetics
  • Insulin-Like Growth Factor I / pharmacokinetics
  • Octreotide / administration & dosage
  • Octreotide / therapeutic use*
  • Pancreatectomy
  • Pancreatic Diseases / pathology

Substances

  • Blood Glucose
  • Insulin
  • Insulin-Like Growth Factor I
  • Growth Hormone
  • Octreotide